Predictive significance of the serum p53 antibody status in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy.
Phase of Trial: Phase IV
Latest Information Update: 02 Aug 2016
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Fluorouracil (Primary) ; Levofolinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Pharmacodynamics; Therapeutic Use
- 02 Aug 2016 New trial record